High Mark Wealth Management LLC Gilead Sciences, Inc. Transaction History
High Mark Wealth Management LLC
- $173 Million
- Q4 2024
A detailed history of High Mark Wealth Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, High Mark Wealth Management LLC holds 180 shares of GILD stock, worth $17,708. This represents 0.01% of its overall portfolio holdings.
Number of Shares
180
Previous 118
52.54%
Holding current value
$17,708
Previous $9,000
77.78%
% of portfolio
0.01%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding GILD
# of Institutions
1,962Shares Held
995MCall Options Held
10.5MPut Options Held
9.85M-
Black Rock Inc. New York, NY121MShares$11.9 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$11.3 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.53 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$6.08 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.92 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $123B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...